Total Payments
$374.92
2018 Payments
$15.95
Companies
7
Transactions
25
Medicare Patients
1,056
Medicare Billing
$57,178
Payment Breakdown by Category
Food & Beverage$374.92 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $374.92 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $148.18 | 9 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $59.30 | 4 | $0 (2018) |
| Genentech USA, Inc. | $50.91 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $39.67 | 3 | $0 (2017) |
| UCB, Inc. | $31.55 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $27.33 | 2 | $0 (2017) |
| Mallinckrodt LLC | $17.98 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $15.95 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($15.95) |
| 2017 | $358.97 | 24 | GlaxoSmithKline, LLC. ($148.18) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Oncology | ||||||
| 12/06/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/13/2017 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Immunology | ||||||
| 09/12/2017 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardio-pulmonary | ||||||
| 08/30/2017 | GlaxoSmithKline, LLC. | BREO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2017 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardio-pulmonary | ||||||
| 07/18/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/28/2017 | GlaxoSmithKline, LLC. | BREO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Immunology | ||||||
| 05/17/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2017 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2017 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardio-pulmonary | ||||||
| 05/02/2017 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), ASMANEX, DULERA | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: VACCINE | ||||||
| 04/04/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/21/2017 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Neurology | ||||||
| 03/20/2017 | GlaxoSmithKline, LLC. | BREO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2017 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 02/23/2017 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Neurology | ||||||
| 02/20/2017 | GlaxoSmithKline, LLC. | BREO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: RESPIRATORY | ||||||
| 02/15/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Immunology | ||||||
| 01/17/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Immunology | ||||||
| 01/11/2017 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug), INCRUSE ELLIPTA | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 13 | 1,056 | 1,207 | $193,926 | $57,178 |
Total Patients
1,056
Total Services
1,207
Medicare Billing
$57,178
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 30 | 106 | $75,366 | $17,851 | 23.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 171 | 222 | $32,818 | $12,719 | 38.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 131 | 131 | $33,165 | $12,519 | 37.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 95 | 110 | $10,989 | $3,983 | 36.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 41 | 42 | $3,608 | $1,761 | 48.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $5,819 | $1,650 | 28.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 63 | 66 | $2,868 | $1,389 | 48.4% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2020 | 141 | 141 | $4,512 | $1,252 | 27.8% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 160 | 163 | $3,912 | $1,097 | 28.0% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 103 | 103 | $3,296 | $973.07 | 29.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2020 | 15 | 15 | $12,225 | $803.73 | 6.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 12 | $3,348 | $617.58 | 18.4% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2020 | 70 | 72 | $1,584 | $439.81 | 27.8% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2020 | 13 | 13 | $416.00 | $122.37 | 29.4% |
About Dr. Kartik Malik, M.D
Dr. Kartik Malik, M.D is a Pulmonary Disease healthcare provider based in Wenatchee, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1710241385.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kartik Malik, M.D has received a total of $374.92 in payments from pharmaceutical and medical device companies, with $15.95 received in 2018. These payments were reported across 25 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($374.92).
As a Medicare-enrolled provider, Malik has provided services to 1,056 Medicare beneficiaries, totaling 1,207 services with total Medicare billing of $57,178. Data is available for 1 year (2020–2020), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Wenatchee, WA
- Active Since 06/28/2012
- Last Updated 07/24/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1710241385
Products in Payments
- BREO ELLIPTA (Drug) $71.12
- NUCALA (Biological) $59.23
- Adempas (Drug) $43.35
- Esbriet (Biological) $38.07
- Vimpat (Drug) $31.55
- ZERBAXA (Drug) $27.71
- XOLAIR (Biological) $27.33
- ACTHAR (Biological) $17.98
- ANORO ELLIPTA (Drug) $17.83
- Xofigo (Drug) $15.95
- Xolair (Biological) $12.84
- PNEUMOVAX 23 (Biological) $11.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Wenatchee
Dr. Jonathan Stoever, M.d, M.D
Pulmonary Disease — Payments: $667.96
Pulmonary Disease $667.96
Dr. Saba Lodhi, Md, MD
Pulmonary Disease — Payments: $420.16
Pulmonary Disease $420.16
Craig Kunz, Md, MD
Pulmonary Disease — Payments: $344.56
Pulmonary Disease $344.56
Dr. Sean Hachey, D.o, D.O
Pulmonary Disease — Payments: $186.66
Pulmonary Disease $186.66
Dr. Robert Stevens, M.d, M.D
Pulmonary Disease
Pulmonary Disease